申请人:Abbott Laboratories
公开号:US04897422A1
公开(公告)日:1990-01-30
Compounds of the formula: ##STR1## where R.sub.1 is amino or methyl; R.sub.2 is C.sub.1 -C.sub.2 alkyl; R.sub.3 is one or more substituents selected from hydrogen, halogen or trihalomethyl; R.sub.4 is one or more substituents selected from hydrogen, halogen, trihalomethyl, C.sub.1 to C.sub.4 alkoxy or C.sub.1 to C.sub.4 alkyl; and M is hydrogen, a pharmaceutically acceptable cation, aroyl, or C.sub.1 to C.sub.6 alkoyl are inhibitors of 5- and/or 12-lipoxygenase enzymes.
该式化合物:##STR1##其中R.sub.1是氨基或甲基;R.sub.2是C.sub.1-C.sub.2烷基;R.sub.3是氢、卤素或三卤甲基中的一个或多个取代基;R.sub.4是氢、卤素、三卤甲基、C.sub.1到C.sub.4烷氧基或C.sub.1到C.sub.4烷基中的一个或多个取代基;M是氢、药用可接受阳离子、芳酰基或C.sub.1到C.sub.6烷酰基,可以抑制5-和/或12-脂氧酶酶。